Grown Rogue International Inc. Stock OTC Markets
Stocks
GRUSF
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
15:40:29 2026-08-26 EDT
|
5-day change | 1st Jan Change | ||
| 0.4601 USD | -2.13% |
|
+0.46% | -10.82% |
| 08-21 | Grown Rogue Shares up 13%, Says Forming Subsidiary to Acquire Cannabis Assets in New York | MT |
| 08-05 | Earnings Flash (GRIN.CN) Grown Rogue International Reports Q2 Revenue $11.3M | MT |
| Market Cap | 115M 98.87M 92.8M 84.76M 160M 10.99B 161M 1.1B 426M 5.54B 433M 423M 18.36B | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 130M 112M 105M 96.02M 181M 12.45B 182M 1.24B 482M 6.28B 490M 479M 20.8B | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.86% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Grown Rogue International Inc.
| 1 day | -2.13% | ||
| 1 week | +0.46% | ||
| Current month | +9.11% | ||
| 1 month | +15.78% | ||
| 3 months | +17.09% | ||
| 6 months | +24.35% | ||
| Current year | -10.82% |
| 1 week | 0.44 |  | 0.51 |
| 1 month | 0.38 | | 0.51 |
| Current year | 0.27 | | 0.52 |
| 1 year | 0.27 | | 0.52 |
| 3 years | 0.17 | | 0.9 |
| 5 years | 0.02 | | 0.9 |
| 10 years | 0 | | 0.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 2018-11-14 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 2016-09-30 |
| Director of Finance/CFO | 42 | 2024-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 2018-11-14 |
J. Strickler
BRD | Director/Board Member | 45 | 2018-11-14 |
Ryan Kee
BRD | Director/Board Member | 42 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.13% | +0.46% | - | - | 117M | |
| +1.01% | +1.01% | -13.78% | -5.57% | 13.27B | |
| +1.98% | +0.33% | -35.14% | -57.05% | 4.95B | |
| +1.85% | -5.05% | -6.75% | -2.34% | 4.64B | |
| +1.58% | -4.23% | -1.29% | -28.74% | 4B | |
| +1.01% | +0.61% | -21.17% | +5.44% | 3.57B | |
| +2.21% | +3.87% | -6.13% | -3.71% | 3.42B | |
| -0.47% | -4.16% | -13.69% | +11.83% | 3.28B | |
| +0.86% | -3.04% | -19.63% | -15.55% | 2.4B | |
| +1.82% | -1.23% | -31.46% | -11.34% | 1.69B | |
| Average | +0.97% | -1.10% | -16.56% | -11.89% | 4.58B | |
| Weighted average by Cap. | +1.27% | -0.82% | -15.41% | -11.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 27.02M 23.19M 21.77M 19.88M 37.52M 2.58B 37.7M 258M 99.82M 1.3B 101M 99.24M 4.31B | 32.43M 27.83M 26.12M 23.86M 45.03M 3.09B 45.25M 309M 120M 1.56B 122M 119M 5.17B |
| Net income | -11.3M -9.7M -9.11M -8.32M -15.7M -1.08B -15.77M -108M -41.76M -544M -42.44M -41.52M -1.8B | 1.73M 1.48M 1.39M 1.27M 2.4M 165M 2.41M 16.49M 6.39M 83.23M 6.49M 6.35M 276M |
| Net Debt | 3.7M 3.18M 2.98M 2.73M 5.14M 353M 5.17M 35.32M 13.69M 178M 13.91M 13.61M 590M | 15.3M 13.13M 12.33M 11.26M 21.24M 1.46B 21.35M 146M 56.53M 736M 57.44M 56.2M 2.44B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-26 | US$0.4601 | -2.13% | 87,541 |
| 26-08-25 | US$0.4701 | -2.06% | 17,990 |
| 26-08-24 | US$0.4800 | -3.03% | 77,092 |
| 26-08-21 | US$0.4950 | +13.17% | 547,253 |
| 26-08-20 | US$0.4374 | -4.50% | 191,761 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
- GRUSF Stock
Select your edition
All financial news and data tailored to specific country editions
